<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37391858</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1297-9716</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Veterinary research</Title><ISOAbbreviation>Vet Res</ISOAbbreviation></Journal><ArticleTitle>Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1.</ArticleTitle><Pagination><StartPage>53</StartPage><MedlinePgn>53</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">53</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13567-023-01188-4</ELocationID><Abstract><AbstractText>The innate immune system provides a defense against invading pathogens by inducing various interferon (IFN)-stimulated genes (ISGs). We recently reported that tripartite motif protein 25 (TRIM25), an important ISG, was highly upregulated in duck embryo hepatocyte cells (DEFs) after infection with duck viral hepatitis A virus type 1 (DHAV-1). However, the mechanism of upregulation of TRIM25 remains unknown. Here we reported that interleukin-22 (IL-22), whose expression was highly facilitated in DEFs and various organs of 1-day-old ducklings after DHAV-1 infection, highly enhanced the IFN-λ-induced production of TRIM25. The treatment with IL-22 neutralizing antibody or the overexpression of IL-22 highly suppressed or facilitated TRIM25 expression, respectively. The phosphorylation of signal transducer and activator of transcription 3 (STAT3) was crucial for the process of IL-22 enhancing IFN-λ-induced TRIM25 production, which was suppressed by WP1066, a novel inhibitor of STAT3 phosphorylation. The overexpression of TRIM25 in DEFs resulted in a high production of IFNs and reduced DHAV-1 replication, whereas the attenuated expression of IFNs and facilitated replication of DHAV-1 were observed in the RNAi group, implying that TRIM25 defended the organism against DHAV-1 propagation by inducing the production of IFNs. In summary, we reported that IL-22 activated the phosphorylation of STAT3 to enhance the IFN-λ-mediated TRIM25 expression and provide a defense against DHAV-1 by inducing IFN production.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>An</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Public Health, Weifang Medical University, Weifang, 261042, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yumei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Public Health, Weifang Medical University, Weifang, 261042, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health, Weifang Medical University, Weifang, 261042, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junhao</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0215-2297</Identifier><AffiliationInfo><Affiliation>School of Public Health, Weifang Medical University, Weifang, 261042, Shandong, China. jhchen@wfmc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>201910240196</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country /></Grant><Grant><GrantID>2019YFA0904900</GrantID><Agency>National Key R&amp;D Program of China</Agency><Country /></Grant><Grant><GrantID>No.2019-6-156</GrantID><Agency>Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities</Agency><Country /></Grant><Grant><GrantID>Lu-Jiao</GrantID><Agency>Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vet Res</MedlineTA><NlmUniqueID>9309551</NlmUniqueID><ISSNLinking>0928-4249</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000095022">Interferon Lambda</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Vet Res. 2024 Apr 9;55(1):47. doi: 10.1186/s13567-024-01307-9</RefSource><PMID Version="1">38594771</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095022" MajorTopicYN="N">Interferon Lambda</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004372" MajorTopicYN="N">Ducks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004371" MajorTopicYN="Y">Hepatitis Virus, Duck</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030041" MajorTopicYN="Y">Hepatitis A virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097043" MajorTopicYN="N">Interleukin-22</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IFN-λ</Keyword><Keyword MajorTopicYN="N">IL-22</Keyword><Keyword MajorTopicYN="N">STAT3</Keyword><Keyword MajorTopicYN="N">TRIM25</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>1</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37391858</ArticleId><ArticleId IdType="pmc">PMC10314556</ArticleId><ArticleId IdType="doi">10.1186/s13567-023-01188-4</ArticleId><ArticleId IdType="pii">10.1186/s13567-023-01188-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009;227:75–86. doi: 10.1111/j.1600-065X.2008.00737.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00737.x</ArticleId><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin FC, Young HA. Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev. 2014;25:369–376. doi: 10.1016/j.cytogfr.2014.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.07.015</ArticleId><ArticleId IdType="pmc">PMC4182113</ArticleId><ArticleId IdType="pubmed">25156421</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccia EM, Battistini A. Early IFN type I response: learning from microbial evasion strategies. Semin Immunol. 2015;27:85–101. doi: 10.1016/j.smim.2015.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2015.03.005</ArticleId><ArticleId IdType="pmc">PMC7129383</ArticleId><ArticleId IdType="pubmed">25869307</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo JS, Kato H, Fujita T. Sensing viral invasion by RIG-I like receptors. Curr Opin Microbiol. 2014;20:131–138. doi: 10.1016/j.mib.2014.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2014.05.011</ArticleId><ArticleId IdType="pubmed">24968321</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14:778–809. doi: 10.1128/CMR.14.4.778-809.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.14.4.778-809.2001</ArticleId><ArticleId IdType="pmc">PMC89003</ArticleId><ArticleId IdType="pubmed">11585785</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2:675–687. doi: 10.1038/nri888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri888</ArticleId><ArticleId IdType="pubmed">12209136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Baldridge MT. Interferon-lambda: a potent regulator of intestinal viral infections. Front Immunol. 2017;8:749. doi: 10.3389/fimmu.2017.00749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00749</ArticleId><ArticleId IdType="pmc">PMC5491552</ArticleId><ArticleId IdType="pubmed">28713375</ArticleId></ArticleIdList></Reference><Reference><Citation>Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H, Fujita T. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem. 2007;282:7576–7581. doi: 10.1074/jbc.M608618200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M608618200</ArticleId><ArticleId IdType="pubmed">17204473</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15:87–103. doi: 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell JE, Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421. doi: 10.1126/science.8197455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8197455</ArticleId><ArticleId IdType="pubmed">8197455</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998;67:227–264. doi: 10.1146/annurev.biochem.67.1.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.67.1.227</ArticleId><ArticleId IdType="pubmed">9759489</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaronson DS, Horvath CM. A road map for those who don’t know JAK-STAT. Science. 2002;296:1653–1655. doi: 10.1126/science.1071545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1071545</ArticleId><ArticleId IdType="pubmed">12040185</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinke A, Barahmand-Pour F, Wohrl S, Stoiber D, Decker T. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol. 1996;16:6937–6944. doi: 10.1128/MCB.16.12.6937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.16.12.6937</ArticleId><ArticleId IdType="pmc">PMC231697</ArticleId><ArticleId IdType="pubmed">8943349</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375–386. doi: 10.1038/nri1604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1604</ArticleId><ArticleId IdType="pubmed">15864272</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A. 2012;109:4239–4244. doi: 10.1073/pnas.1114981109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1114981109</ArticleId><ArticleId IdType="pmc">PMC3306696</ArticleId><ArticleId IdType="pubmed">22371602</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, Smith JK, Pernet O, Guo H, Nusbaum R, Zack JA, Freiberg AN, Su L, Lee B, Cheng G. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity. 2013;38:92–105. doi: 10.1016/j.immuni.2012.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.11.005</ArticleId><ArticleId IdType="pmc">PMC3698975</ArticleId><ArticleId IdType="pubmed">23273844</ArticleId></ArticleIdList></Reference><Reference><Citation>Torok M, Etkin LD. Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation. 2001;67:63–71. doi: 10.1046/j.1432-0436.2001.067003063.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-0436.2001.067003063.x</ArticleId><ArticleId IdType="pubmed">11428128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozato K, Shin DM, Chang TH, Morse HC., 3rd TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849–860. doi: 10.1038/nri2413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2413</ArticleId><ArticleId IdType="pmc">PMC3433745</ArticleId><ArticleId IdType="pubmed">18836477</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajsbaum R, Garcia-Sastre A, Versteeg GA. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol. 2014;426:1265–1284. doi: 10.1016/j.jmb.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.12.005</ArticleId><ArticleId IdType="pmc">PMC3945521</ArticleId><ArticleId IdType="pubmed">24333484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Wang X, Tu F, Wang Q, Fan Z, Gao G. TRIM25 is required for the antiviral activity of zinc finger antiviral protein. J Virol. 2017;91:e00088–e00017. doi: 10.1128/JVI.00088-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00088-17</ArticleId><ArticleId IdType="pmc">PMC5391446</ArticleId><ArticleId IdType="pubmed">28202764</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MM, Lau Z, Cheung P, Aguilar EG, Schneider WM, Bozzacco L, Molina H, Buehler E, Takaoka A, Rice CM, Felsenfeld DP, MacDonald MR. TRIM25 enhances the antiviral action of zinc-finger antiviral protein (ZAP) PLoS Pathog. 2017;13:e1006145. doi: 10.1371/journal.ppat.1006145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006145</ArticleId><ArticleId IdType="pmc">PMC5245905</ArticleId><ArticleId IdType="pubmed">28060952</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffer AM, Jones G, Kasdon EJ, Schlossman SF. Local transfer of delayed hypersensitivity by T lymphocytes. J Immunol. 1973;111:1268–1269. doi: 10.4049/jimmunol.111.4.1268.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.111.4.1268</ArticleId><ArticleId IdType="pubmed">4542301</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikel G, Choudhury NR, Michlewski G. The role of Trim25 in development, disease and RNA metabolism. Biochem Soc Trans. 2016;44:1045–1050. doi: 10.1042/BST20160077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20160077</ArticleId><ArticleId IdType="pubmed">27528750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 2007;446:916–920. doi: 10.1038/nature05732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05732</ArticleId><ArticleId IdType="pubmed">17392790</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Kirchhofer A, Shin YC, Inn KS, Liang C, Cui S, Myong S, Ha T, Hopfner KP, Jung JU. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A. 2008;105:16743–16748. doi: 10.1073/pnas.0804947105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804947105</ArticleId><ArticleId IdType="pmc">PMC2575490</ArticleId><ArticleId IdType="pubmed">18948594</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Now H, Kim WJ, Kim N, Yoo JY. Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform. Sci Rep. 2016;6:23377. doi: 10.1038/srep23377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23377</ArticleId><ArticleId IdType="pmc">PMC4800306</ArticleId><ArticleId IdType="pubmed">26996158</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Zhang R, Yu H, Wang J, Xue W, Chen J, Lin S, Wang Y, Xie Z, Jiang S. Quantitative proteomic analysis uncovers the mediation of endoplasmic reticulum stress-induced autophagy in DHAV-1-infected DEF cells. Int J Mol Sci. 2019;20:6160. doi: 10.3390/ijms20246160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246160</ArticleId><ArticleId IdType="pmc">PMC6940786</ArticleId><ArticleId IdType="pubmed">31817666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hoelscher C, Dumoutier L, Renauld JC, Suerbaum S, Staeheli P, Diefenbach A. Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol. 2015;16:698–707. doi: 10.1038/ni.3180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3180</ArticleId><ArticleId IdType="pmc">PMC4589158</ArticleId><ArticleId IdType="pubmed">26006013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol. 2006;80:4501–4509. doi: 10.1128/JVI.80.9.4501-4509.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.9.4501-4509.2006</ArticleId><ArticleId IdType="pmc">PMC1472004</ArticleId><ArticleId IdType="pubmed">16611910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Xiao Q, Song H, Ma F, Xu F, Peng D, Li N, Wang X, Niu J, Gao P, Qin FX, Cheng G. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication. Cell Mol Immunol. 2018;15:272–281. doi: 10.1038/cmi.2016.67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2016.67</ArticleId><ArticleId IdType="pmc">PMC5843613</ArticleId><ArticleId IdType="pubmed">28194021</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol. 2004;4:679–691. doi: 10.1016/j.intimp.2004.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2004.01.008</ArticleId><ArticleId IdType="pubmed">15120652</ArticleId></ArticleIdList></Reference><Reference><Citation>Honma M, Minami-Hori M, Takahashi H, Iizuka H. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-beta and STAT-3 activating cytokines, IFN-gamma, IL-6, and IL-22. J Dermatol Sci. 2012;65:134–140. doi: 10.1016/j.jdermsci.2011.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdermsci.2011.11.011</ArticleId><ArticleId IdType="pubmed">22189341</ArticleId></ArticleIdList></Reference><Reference><Citation>Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002;277:33676–33682. doi: 10.1074/jbc.M204204200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M204204200</ArticleId><ArticleId IdType="pubmed">12087100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282–289. doi: 10.1038/nm1720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1720</ArticleId><ArticleId IdType="pubmed">18264109</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutz S, Ouyang W. Regulation of interleukin-10 and interleukin-22 expression in T helper cells. Curr Opin Immunol. 2011;23:605–612. doi: 10.1016/j.coi.2011.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.07.018</ArticleId><ArticleId IdType="pubmed">21862302</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores RA, Cammayo PLT, Nguyen BT, Fernandez-Colorado CP, Kim S, Kim WH, Min W. Duck interleukin-22: identification and expression analysis in Riemerella anatipestifer infection. J Immunol Res. 2021;2021:3862492. doi: 10.1155/2021/3862492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/3862492</ArticleId><ArticleId IdType="pmc">PMC8601822</ArticleId><ArticleId IdType="pubmed">34805416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang J, Meng R, Jiang Y, Liang S, Zhang Y, Xie M, Zhou Z, Hou S. Host differences affecting resistance and susceptibility of the second generation of a Pekin duck flock to duck hepatitis a virus genotype 3. Front Microbiol. 2017;8:1128. doi: 10.3389/fmicb.2017.01128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01128</ArticleId><ArticleId IdType="pmc">PMC5474462</ArticleId><ArticleId IdType="pubmed">28674528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Cao C, Qu Z, Zhang W, Liu Y, Qi H, Hao C, Zhang W, Gao M, Wang J, Ma B. Pathogenicity of duck hepatitis a virus type 3 and innate immune responses of the ducklings to virulent DHAV-3. Mol Immunol. 2018;95:30–38. doi: 10.1016/j.molimm.2018.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2018.01.007</ArticleId><ArticleId IdType="pubmed">29407574</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Wang M, Cheng A, Zhao XX, Liu M, Zhu D, Chen S, Jia R, Yang Q, Wu Y, Zhang S, Liu Y, Yu Y, Zhang L, Sun K, Chen X. Cytokine storms are primarily responsible for the rapid death of ducklings infected with duck hepatitis a virus type 1. Sci Rep. 2018;8:6596. doi: 10.1038/s41598-018-24729-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24729-w</ArticleId><ArticleId IdType="pmc">PMC5920089</ArticleId><ArticleId IdType="pubmed">29700351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Cao C, Liu Y, Qi H, Zhang W, Hao C, Chen H, Zhang Q, Zhang W, Gao M, Wang J, Ma B. Comparative liver transcriptome analysis in ducklings infected with duck hepatitis a virus 3 (DHAV-3) at 12 and 48 hours post-infection through RNA-seq. Vet Res. 2018;49:52. doi: 10.1186/s13567-018-0545-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13567-018-0545-7</ArticleId><ArticleId IdType="pmc">PMC6011267</ArticleId><ArticleId IdType="pubmed">29925406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JH, Zhang RH, Lin SL, Li PF, Lan JJ, Gao JM, Xie ZJ, Li FC, Jiang SJ. Identification of a functional nuclear localization signal in 3D(pol)/3CD of duck hepatitis a virus 1. Virus Res. 2019;270:197670. doi: 10.1016/j.virusres.2019.197670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2019.197670</ArticleId><ArticleId IdType="pubmed">31330206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SL, Cong RC, Zhang RH, Chen JH, Xia LL, Xie ZJ, Wang Y, Zhu YL, Jiang SJ. Circulation and in vivo distribution of duck hepatitis a virus types 1 and 3 in infected ducklings. Arch Virol. 2016;161:405–416. doi: 10.1007/s00705-015-2648-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2648-z</ArticleId><ArticleId IdType="pubmed">26597185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, Mujib S, Benko E, Kovacs C, Shin LY, Grin A, Kandel G, Loutfy M, Ostrowski M, Gommerman JL, Kaushic C, Kaul R. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 2012;5:670–680. doi: 10.1038/mi.2012.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2012.72</ArticleId><ArticleId IdType="pubmed">22854709</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue M, Zhao J, Ying L, Fu F, Li L, Ma Y, Shi H, Zhang J, Feng L, Liu P. IL-22 suppresses the infection of porcine enteric coronaviruses and rotavirus by activating STAT3 signal pathway. Antiviral Res. 2017;142:68–75. doi: 10.1016/j.antiviral.2017.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.006</ArticleId><ArticleId IdType="pmc">PMC7113769</ArticleId><ArticleId IdType="pubmed">28322925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4:69–77. doi: 10.1038/ni875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni875</ArticleId><ArticleId IdType="pubmed">12483210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003;4:63–68. doi: 10.1038/ni873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni873</ArticleId><ArticleId IdType="pubmed">12469119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, Schwemmle M, Gunther S, Drosten C, Michiels T, Staeheli P. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol. 2010;84:5670–5677. doi: 10.1128/JVI.00272-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00272-10</ArticleId><ArticleId IdType="pmc">PMC2876583</ArticleId><ArticleId IdType="pubmed">20335250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 2008;4:e1000017. doi: 10.1371/journal.ppat.1000017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000017</ArticleId><ArticleId IdType="pmc">PMC2265414</ArticleId><ArticleId IdType="pubmed">18369468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hines IN, Kremer M, Isayama F, Perry AW, Milton RJ, Black AL, Byrd CL, Wheeler MD. Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology. 2007;46:229–241. doi: 10.1002/hep.21674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21674</ArticleId><ArticleId IdType="pubmed">17596893</ArticleId></ArticleIdList></Reference><Reference><Citation>Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 2004;427:848–853. doi: 10.1038/nature02343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02343</ArticleId><ArticleId IdType="pubmed">14985764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao B, Duan Z, Xu W, Xiong S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology. 2009;50:424–433. doi: 10.1002/hep.23011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23011</ArticleId><ArticleId IdType="pubmed">19585648</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour SMG, Mohamed FF, ElBakrey RM, Eid AAM, Mor SK, Goyal SM. Outbreaks of duck hepatitis a virus in egyptian duckling flocks. Avian Dis. 2019;63:68–74. doi: 10.1637/11975-092118-Reg.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1637/11975-092118-Reg.1</ArticleId><ArticleId IdType="pubmed">31251521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamomae M, Kameyama M, Ishii J, Nabe M, Ogura Y, Iseki H, Yamamoto Y, Mase M. An outbreak of duck hepatitis a virus type 1 infection in Japan. J Vet Med Sci. 2017;79:917–920. doi: 10.1292/jvms.16-0646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.16-0646</ArticleId><ArticleId IdType="pmc">PMC5447982</ArticleId><ArticleId IdType="pubmed">28413174</ArticleId></ArticleIdList></Reference><Reference><Citation>Doan HT, Le XT, Do RT, Hoang CT, Nguyen KT, Le TH. Molecular genotyping of duck hepatitis a viruses (DHAV) in Vietnam. J Infect Dev Ctries. 2016;10:988–995. doi: 10.3855/jidc.7239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.7239</ArticleId><ArticleId IdType="pubmed">27694732</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyerich K, Dimartino V, Cavani A. IL-17 and IL-22 in immunity: driving protection and pathology. Eur J Immunol. 2017;47:607–614. doi: 10.1002/eji.201646723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646723</ArticleId><ArticleId IdType="pubmed">28295238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronacher K, Sinha R, Cestari M. IL-22: an underestimated player in natural resistance to tuberculosis? Front Immunol. 2018;9:2209. doi: 10.3389/fimmu.2018.02209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02209</ArticleId><ArticleId IdType="pmc">PMC6167461</ArticleId><ArticleId IdType="pubmed">30319650</ArticleId></ArticleIdList></Reference><Reference><Citation>Saalim M, Resham S, Manzoor S, Ahmad H, Jaleel S, Ashraf J, Imran M, Naseem S. IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma. Tumour Biol. 2016;37:105–114. doi: 10.1007/s13277-015-4294-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-4294-1</ArticleId><ArticleId IdType="pubmed">26541758</ArticleId></ArticleIdList></Reference><Reference><Citation>Neil JA, Matsuzawa-Ishimoto Y, Kernbauer-Holzl E, Schuster SL, Sota S, Venzon M, Dallari S, Galvao Neto A, Hine A, Hudesman D, Loke P, Nice TJ, Cadwell K. IFN-I and IL-22 mediate protective effects of intestinal viral infection. Nat Microbiol. 2019;4:1737–1749. doi: 10.1038/s41564-019-0470-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0470-1</ArticleId><ArticleId IdType="pmc">PMC6871771</ArticleId><ArticleId IdType="pubmed">31182797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L, Fang H, Xia S, Zhang R, Li L, Ochando J, Xu J, Ding Y. STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis. Biochem Biophys Res Commun. 2018;501:563–569. doi: 10.1016/j.bbrc.2018.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.05.042</ArticleId><ArticleId IdType="pubmed">29750958</ArticleId></ArticleIdList></Reference><Reference><Citation>Eidenschenk C, Rutz S, Liesenfeld O, Ouyang W. Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol. 2014;380:213–236.</Citation><ArticleIdList><ArticleId IdType="pubmed">25004820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S, Dou C, Xin N, Wang J, Wang J, Li P, Fu L, Shen X, Cui G, Dong R, Lu J, Zhang Y. Expression of interleukin-22 in myasthenia gravis. Scand J Immunol. 2013;78:98–107. doi: 10.1111/sji.12057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12057</ArticleId><ArticleId IdType="pubmed">23617779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, Fernandez EM, Blanc F, De Trez C, Van Maele L, Dumoutier L, Huerre MR, Eberl G, Si-Tahar M, Gosset P, Renauld JC, Sirard JC, Faveeuw C, Trottein F. Interleukin-22 reduces lung inflammation during influenza a virus infection and protects against secondary bacterial infection. J Virol. 2013;87:6911–6924. doi: 10.1128/JVI.02943-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02943-12</ArticleId><ArticleId IdType="pmc">PMC3676141</ArticleId><ArticleId IdType="pubmed">23596287</ArticleId></ArticleIdList></Reference><Reference><Citation>Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005;129:969–984. doi: 10.1053/j.gastro.2005.06.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2005.06.071</ArticleId><ArticleId IdType="pubmed">16143135</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12:383–390. doi: 10.1038/ni.2025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2025</ArticleId><ArticleId IdType="pubmed">21502992</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhl H. Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons? Front Immunol. 2013;4:18. doi: 10.3389/fimmu.2013.00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00018</ArticleId><ArticleId IdType="pmc">PMC3562761</ArticleId><ArticleId IdType="pubmed">23382730</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747–785. doi: 10.1146/annurev-immunol-032414-112123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032414-112123</ArticleId><ArticleId IdType="pmc">PMC4407497</ArticleId><ArticleId IdType="pubmed">25706098</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy DE, Lee CK. What does Stat3 do? J Clin Invest. 2002;109:1143–1148. doi: 10.1172/JCI0215650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI0215650</ArticleId><ArticleId IdType="pmc">PMC150972</ArticleId><ArticleId IdType="pubmed">11994402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WB, Levy DE, Lee CK. STAT3 negatively regulates type I IFN-mediated antiviral response. J Immunol. 2011;187:2578–2585. doi: 10.4049/jimmunol.1004128.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1004128</ArticleId><ArticleId IdType="pubmed">21810606</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res. 1999;19:563–573. doi: 10.1089/107999099313695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107999099313695</ArticleId><ArticleId IdType="pubmed">10433356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Sommerville LJ, Cuneo A, Kelemen SE, Autieri MV. Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia. Am J Pathol. 2008;173:901–909. doi: 10.2353/ajpath.2008.080163.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080163</ArticleId><ArticleId IdType="pmc">PMC2527072</ArticleId><ArticleId IdType="pubmed">18669613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Tan Z, Zhang R, Kotenko SV, Liang P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem. 2002;277:7341–7347. doi: 10.1074/jbc.M106043200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M106043200</ArticleId><ArticleId IdType="pubmed">11706020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, Anantha S, Dickensheets H, Dumoutier L, Renauld JC, Zdanov A, Donnelly RP, Kotenko SV. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol. 2004;172:2006–2010. doi: 10.4049/jimmunol.172.4.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.4.2006</ArticleId><ArticleId IdType="pubmed">14764663</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliopoulos MG, Lethier M, van der Veen AG, Haubrich K, Hennig J, Kowalinski E, Stevens RV, Martin SR, Reis C, Cusack S, Rittinger K. Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition. Nat Commun. 2018;9:1820. doi: 10.1038/s41467-018-04214-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04214-8</ArticleId><ArticleId IdType="pmc">PMC5940772</ArticleId><ArticleId IdType="pubmed">29739942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30:16–34. doi: 10.3109/08830185.2010.529976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2010.529976</ArticleId><ArticleId IdType="pubmed">21235323</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Vicente M, Medrano LM, Resino S, Garcia-Sastre A, Martinez I. TRIM25 in the regulation of the antiviral innate immunity. Front Immunol. 2017;8:1187. doi: 10.3389/fimmu.2017.01187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01187</ArticleId><ArticleId IdType="pmc">PMC5614919</ArticleId><ArticleId IdType="pubmed">29018447</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerson NR, Zhou L, Guo YR, Zhao C, Tao YJ, Krug RM, Sawyer SL. Nuclear TRIM25 specifically targets influenza virus ribonucleoproteins to block the onset of RNA chain elongation. Cell Host Microbe. 2017;22:627–638e7. doi: 10.1016/j.chom.2017.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.10.003</ArticleId><ArticleId IdType="pmc">PMC6309188</ArticleId><ArticleId IdType="pubmed">29107643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>